| |
Cancer Models: MRI/MRS Assessment
Room 4A Monday 14:00 - 16:00
Time |
Prog # |
Computer# |
|
14:00 |
3173 |
16 |
Difference in Early
Intratumoral Changes Induced by Single Dose and Fractionated
Radiotherapy in Rat
Rhabdomyosarcoma
Measured with Diffusion- And Perfusion-Weighted Magnetic Resonance
Imaging
Frederik De Keyzer1,
Vincent Vandecaveye1, Jill Eckelmans1, Feng Chen1,
Ronald R. Peeters1, Pascal Hamaekers1,
Yicheng Ni1,
Robert Hermans1, Sandra Nuyts1, Willy Landuyt2,
Hilde Bosmans1
1University
Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; 2Catholic
University of Leuven (KUL), Leuven, Vlaams
Brabant, Belgium |
14:00 |
3174 |
17 |
Comparison of T1ρ
and Diffusion Response Following Chemotherapy in Mouse EL4 Tumors at 9.4
T
Mikko
I. Kettunen1, De-En Hu1, Kevin M. Brindle1
1University
of Cambridge, Cambridge, UK |
14:00 |
3175 |
18 |
Evaluation of
Salmonella-Based Suicide Gene Transfer in a Rodent Tumor Model Using
In Vivo 19F MR
Spectroscopy
Tom Dresselaers1,
Jan Theys2, Ludwig Dubois2, Willy Landuyt1,
Paul Van Hecke1, Philippe Lambin2
1K.U.Leuven,
Leuven, Belgium, Belgium; 2Maastricht Radiation Oncology
Lab/GROW, Maastricht, The Netherlands,
Netherlands |
14:30 |
3176 |
18 |
The PPARγ Inhibitor
GW9662 Attenuates Phenylbutyrate-Induced Lipid Metabolite Accumulation
in DU145
Prostate Cancer Cells
Matthew Milkevitch1,
Nancy J. Beardsley1, Edward J. Delikatny1
1University
of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U |
14:30 |
3177 |
17 |
Apparent Diffusion
Coefficient Predicts Survival in a Transgenic Model of Glioma
Patrick McConville1,
Jonathan B. Moody1, Alicia R. Kreger1, William L.
Elliott1, Wilbur R. Leopold1, Brian D. Ross2,
Eric
C. Holland3
1Molecular
Imaging Research, Inc., Ann Arbor, Michigan, USA; 2University
of Michigan, Ann Arbor, Michigan, USA; 3Memorial
Sloan-Kettering Cancer Center, New York, New York, USA |
14:30 |
3178 |
16 |
Dose Response of Rat
GH3 Prolactinomas to 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA)
Assessed by
Dynamic Contrast
Enhanced MRI
Dominick John McIntyre1,
Lesley D. McPhail1, Christian Ludwig2, Philip
Kestell3, John Richard Griffiths1,
Lloyd R. Kelland4,
Simon Philip Robinson1
1St
George's, University of London, London, UK; 2University of
Birmingham, Birmingham, UK; 3University of Auckland,
Auckland, New Zealand; 4Antisoma Research Ltd, London, UK |
15:00 |
3179 |
16 |
Assesing the Response
of Pre-Clinical Tumor Models to Anti-Neoplastic Therapies Using
Functional Diffusion
Mapping (FDM)
Bradford A. Moffat1,
Daniel E. Hall1, Benjamin Hoff1, Thomas L.
Chenevert1, Brian D. Ross1
1University
of Michigan, Ann Arbor, Michigan, USA |
15:00 |
3180 |
17 |
Assessment of
Emerging Chemotherapeutic Tumor Resistance to BCNU
Victor D. Schepkin1,
Kuei C. Lee1, Kyle Kuszpit1, Mukilan Muthuswami1,
Thomas L. Chenevert1, Alnawaz Rehemtulla1,
Brian D. Ross1
1University
of Michigan Medical School, Ann Arbor, Michigan, USA |
15:00 |
3181 |
18 |
Choline Phospholipid
Metabolism in Human Ovarian Tumor Progression: A MRS Study
Egidio Iorio1, Alessandro Ricci1, Delia
Mezzanzanica2, Francesca Spadaro1, Carlo Ramoni1,
Rossella Canese1, Carmela
Rozera1, Massimo Spada1, Filippo Belardelli1,
Sandra D'Ascenzo3, Vincenza Dolo3, Silvana
Canevari2, Franca Podo1
1Istituto
Superiore di Sanità, Roma, Italy; 2Istituto Nazionale Tumori,
Milano, Italy; 3University of L'Aquila, L'Aquila, Italy |
15:30 |
3182 |
18 |
Magnetic Resonance
Spectroscopy: A Non-Invasive Tool for Monitoring Histone Deacetylase
Inhibition
Madhuri
Sankaranarayanapillai1, William PingYiu Tong1,
Ashutosh Pal1, William G. Bornmann1, Juri G.
Gelovani1,
Sabrina M. Ronen1
1UT
M.D.Anderson Cancer Center, Houston, Texas, USA |
15:30 |
3183 |
17 |
Accelerated
Evaluation of Tumor Treatment Response by Diffusion MRI
Jonathan Bryan Moody1,
Patrick James McConville1, Richard J. Lister1,
Bradford A. Moffat2, Thomas L. Chenevert2,
Alnawaz Rehemtulla2,
Brian D. Ross2, William L. Elliott1, Wilbur R.
Leopold1
1MIR
Preclinical Services, Ann Arbor, Michigan, USA; 2University
of Michigan, Ann Arbor, Michigan, USA |
15:30 |
3184 |
16 |
Statistical Power of
Two Quantitative Biomarkers for Analysis of DCE-MRI Studies of Agents
Targeting Tumour
Vasculature
Dominick John McIntyre1,
Simon Phili Robinson1, Philip Worthington2, John
Richard Griffiths1, John C. Waterton2
1St
George's, University of London, London, UK; 2AstraZeneca,
Alderley Park, Macclesfield, UK |
|